SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-08-001624
Filing Date
2008-03-04
Accepted
2008-03-04 15:26:56
Documents
14
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 BIOCRYST PHARMACEUTICALS, INC. g12086e10vk.htm 10-K 644112
2 EX-10.1 ANNUAL INCENTIVE PLAN g12086exv10w1.htm EX-10.1 19189
3 EX-10.2 EXECUTIVE RELOCATION POLICY g12086exv10w2.htm EX-10.2 16651
4 EX-10.3 AMENDMENT TO EMPLOYMENT LETTER AGREEMENT g12086exv10w3.htm EX-10.3 7775
5 EX-10.4 FORM OF NOTICE OF GRANT NON-EMPLOYEE DIRECTOR g12086exv10w4.htm EX-10.4 40261
6 EX-10.5 FORM OF NOTICE OF GRANT OF STOCK OPTION g12086exv10w5.htm EX-10.5 50627
7 EX-10.6 AMENDMENT #3 TO THE AGREEMENT g12086exv10w6.htm EX-10.6 12834
8 EX-23 CONSENT OF ERNST & YOUNG g12086exv23.htm EX-23 4503
9 EX-31.1 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER g12086exv31w1.htm EX-31.1 8563
10 EX-31.2 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER g12086exv31w2.htm EX-31.2 8549
11 EX-32.1 SECTION 906 CERTIFICATION OF THE CEO g12086exv32w1.htm EX-32.1 2568
12 EX-32.2 SECTION 906 CERTIFICATION OF THE CFO g12086exv32w2.htm EX-32.2 2630
13 GRAPHIC g12086g1208601.gif GRAPHIC 11818
14 GRAPHIC g12086g1208600.gif GRAPHIC 9166
  Complete submission text file 0000950144-08-001624.txt   848893
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-23186 | Film No.: 08663437
SIC: 2836 Biological Products, (No Diagnostic Substances)